Acute myocardial infarction. Results of the ASSENT-3 Trial
- PMID: 12447153
Acute myocardial infarction. Results of the ASSENT-3 Trial
Comment on
-
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.Lancet. 2001 Aug 25;358(9282):605-13. doi: 10.1016/S0140-6736(01)05775-0. Lancet. 2001. PMID: 11530146 Clinical Trial.